We are live on ! Find out more
MIFH

Migdal Insurance & Financial Holdings Portfolio holdings

AUM $15.6B
1-Year Est. Return 71.29%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+71.29%
3 Year Est. Return
+173.57%
5 Year Est. Return
+196.76%
10 Year Est. Return
+800.33%
AUM
$10.4B
AUM Growth
+$854M
Cap. Flow
+$343M
Cap. Flow %
3.31%
Top 10 Hldgs %
32.76%
Holding
757
New
90
Increased
169
Reduced
311
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Consumer Discretionary 10.36%
3 Industrials 9.3%
4 Communication Services 8.47%
5 Financials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
651
CareDx
CDNA
$2.45B
$4K ﹤0.01%
85
-50
-37% -$2.61K
CHGG icon
652
Chegg
CHGG
$88.9M
$4K ﹤0.01%
137
+54
+65% +$2.19K
CHWY icon
653
Chewy
CHWY
$9.15B
$4K ﹤0.01%
68
+17
+33% +$1.11K
EEFT icon
654
Euronet Worldwide
EEFT
$2.66B
$4K ﹤0.01%
36
+7
+24% +$832
OPEN icon
655
Opendoor
OPEN
$3.39B
$4K ﹤0.01%
255
+100
+65% +$1.85K
RGEN icon
656
Repligen
RGEN
$9.35B
$4K ﹤0.01%
14
RNLX
657
DELISTED
Renalytix plc American Depositary Shares
RNLX
$4K ﹤0.01%
255
-154
-38% -$3.08K
CDAK
658
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$4K ﹤0.01%
341
-204
-37% -$2.83K
OPT
659
DELISTED
Opthea Limited American Depositary Shares
OPT
$4K ﹤0.01%
547
-329
-38% -$2.4K
BMRN icon
660
BioMarin Pharmaceuticals
BMRN
$13.6B
$3K ﹤0.01%
31
-241
-89% -$19.9K
GLUE icon
661
Monte Rosa Therapeutics
GLUE
$1.36B
$3K ﹤0.01%
124
-126
-50% -$2.64K
IMDX
662
Insight Molecular Diagnostics
IMDX
$147M
$3K ﹤0.01%
76
-46
-38% -$2.65K
UPLD icon
663
Upland Software
UPLD
$14.9M
$3K ﹤0.01%
16
-1
-6% -$254
BMBL icon
664
Bumble
BMBL
$344M
$2K ﹤0.01%
51
+21
+70% +$894
FOUR icon
665
Shift4
FOUR
$3.47B
$2K ﹤0.01%
37
+15
+68% +$953
HEPA
666
DELISTED
Hepion Pharmaceuticals
HEPA
$2K ﹤0.01%
2
-1
-33% -$1.37K
MBRX icon
667
Moleculin Biotech
MBRX
$3.71M
$2K ﹤0.01%
4
-2
-33% -$1.77K
PLX icon
668
Protalix BioTherapeutics
PLX
$211M
$2K ﹤0.01%
2,432
-1,568
-39% -$1.64K
SLVM icon
669
Sylvamo
SLVM
$1.53B
$2K ﹤0.01%
69
-137
-67% -$3.99K
TRHC
670
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$2K ﹤0.01%
146
-5
-3% -$91
TYME
671
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2K ﹤0.01%
3,019
-1,820
-38% -$1.56K
CNSP icon
672
CNS Pharmaceuticals
CNSP
$7.32M
0
HPQ icon
673
HP
HPQ
$26.8B
$1K ﹤0.01%
23
OGN icon
674
Organon & Co
OGN
$3.59B
$1K ﹤0.01%
30
VRM icon
675
Vroom Inc
VRM
$52.1M
$1K ﹤0.01%
1

Similar funds

Migdal Insurance & Financial Holdings's Q4 2021 Portfolio in Review

As of Q4 2021, Migdal Insurance & Financial Holdings held 757 positions worth $10.4B, up 9% from $9.5B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Migdal Insurance & Financial Holdings deployed $343M of net new capital in Q4 2021, opening 90 new positions and adding to 169 existing holdings. Its largest new stake was State Street SPDR S&P Metals & Mining ETF: 1,604,200 shares worth $71.8M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was US Global Jets ETF, an estimated $147M trimmed.

  • Migdal Insurance & Financial Holdings's largest Q4 2021 buy was State Street SPDR S&P Metals & Mining ETF: 1,604,200 shares worth $71.8M.
  • Migdal Insurance & Financial Holdings added most to State Street Health Care Select Sector SPDR ETF in Q4 2021, an estimated $134M increase.
  • Migdal Insurance & Financial Holdings's biggest Q4 2021 reduction was US Global Jets ETF, cutting an estimated $147M.
  • Migdal Insurance & Financial Holdings fully exited iShares Cybersecurity and Tech ETF in Q4 2021, selling an estimated $113M.
  • Migdal Insurance & Financial Holdings's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2021.
  • Migdal Insurance & Financial Holdings opened 90 new positions and closed 75 in Q4 2021.
  • Migdal Insurance & Financial Holdings's portfolio value rose 9% quarter-over-quarter to $10.4B.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2021, filed 2 Feb 2022.